Bandhan Healthcare Fund
- NAV as on 9 Nov 2026
- ₹11.41+2.07%1 day
- Return since launch
- 12.3%
- 52-week range
- ₹9.07 — ₹11.43
- AUM
- ₹327 Cr
Bandhan Healthcare Fund is a Sectoral-Pharma equity fund from Bandhan Mutual Fund with ₹327 Cr under management, launched in 2025. The expense ratio is 2.78% and the SEBI riskometer reading is Very High.
Performance
Bandhan Healthcare Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +14.6% against +19.5% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | 6.9% | −1.5 pts | 8.4% | 8.5% |
| 3M | 1.5% | −2.2 pts | 3.7% | 3.7% |
| 6M | 11.7% | −2.3 pts | 14.0% | 13.6% |
Since launch (10 Nov 2025): 12.3%
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
2.81%
Expense ratio as on 5 Nov 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 2.10%
- Brokerage
- 0.12%
- Transaction charges
- 0.01%
- Statutory levies
- 0.58%
- Exit load
- Exit load of 0.50%, if redeemed within 30 days.
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- BSE Healthcare TRI
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
Portfolio
Bandhan Healthcare Fund portfolio
Portfolio as of 30 Sep 2026
Asset allocation
- Equity93.5%
- Debt0.0%
- Other6.4%
Market cap split
- Large31.2%
- Mid33.4%
- Small35.4%
- P/E
- 39.37
- P/B
- 5.11
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 9.74% | ₹31.79 Cr | +10.11% | +9.65% | — |
| Others | Others | 6.45% | ₹21.08 Cr | +2.70% | +0.06% | — |
| Cipla Ltd. | Healthcare | 6.18% | ₹20.19 Cr | +6.82% | +6.72% | — |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 5.75% | ₹18.78 Cr | +8.08% | +8.97% | — |
| Max Healthcare Institute Ltd. | Healthcare | 5.27% | ₹17.20 Cr | +6.30% | +7.14% | — |
| Lupin Ltd. | Healthcare | 4.35% | ₹14.21 Cr | +1.69% | +3.81% | — |
| Divi's Laboratories Ltd. | Healthcare | 4.27% | ₹13.94 Cr | +6.12% | +7.40% | — |
| Shilpa Medicare Ltd. | Healthcare | 4.17% | ₹13.61 Cr | +2.78% | +1.60% | — |
| Aurobindo Pharma Ltd. | Healthcare | 4.10% | ₹13.38 Cr | +3.92% | +2.87% | — |
| Dr. Reddy's Laboratories Ltd. | Healthcare | 3.78% | ₹12.33 Cr | +4.21% | +7.12% | — |
| Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | 3.39% | ₹11.08 Cr | +2.28% | +1.84% | — |
| Torrent Pharmaceuticals Ltd. | Healthcare | 3.23% | ₹10.56 Cr | — | — | — |
| Gland Pharma Ltd. | Healthcare | 3.11% | ₹10.15 Cr | — | — | — |
| Zydus Lifesciences Ltd. | Healthcare | 2.82% | ₹9.22 Cr | +2.74% | — | — |
| Narayana Hrudayalaya Ltd. | Healthcare | 2.74% | ₹8.96 Cr | +1.53% | — | — |
| Syngene International Ltd. | Healthcare | 2.46% | ₹8.04 Cr | +1.77% | +1.86% | — |
| Rainbow Children's Medicare Ltd. | Healthcare | 2.21% | ₹7.23 Cr | +2.19% | +1.92% | — |
| Eris Lifesciences Ltd. | Healthcare | 2.19% | ₹7.15 Cr | +2.01% | — | — |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 2.14% | ₹7.00 Cr | +3.42% | +2.97% | — |
| Global Health Ltd. | Healthcare | 1.88% | ₹6.14 Cr | +2.85% | +2.46% | — |
| Novartis India Ltd. | Healthcare | 1.88% | ₹6.13 Cr | +0.44% | — | — |
| Pfizer Ltd. | Healthcare | 1.54% | ₹5.04 Cr | +1.79% | +1.73% | — |
| Sanofi India Ltd. | Healthcare | 1.50% | ₹4.89 Cr | +1.27% | +1.18% | — |
| Ipca Laboratories Ltd. | Healthcare | 1.48% | ₹4.82 Cr | +1.85% | +0.59% | — |
| Healthcare Global Enterprises Ltd. | Healthcare | 1.33% | ₹4.33 Cr | +1.94% | +0.84% | — |
| Thyrocare Technologies Ltd. | Healthcare | 1.31% | ₹4.27 Cr | +0.68% | — | — |
| Jubilant Pharmova Ltd. | Healthcare | 1.26% | ₹4.12 Cr | — | +0.90% | — |
| Ajanta Pharma Ltd. | Healthcare | 1.22% | ₹3.98 Cr | +2.87% | +3.08% | — |
| Sai Life Sciences Ltd. | Healthcare | 1.17% | ₹3.81 Cr | +1.15% | +1.78% | — |
| Alivus Life Sciences Ltd | Healthcare | 1.15% | ₹3.75 Cr | +1.15% | — | — |
| Sai Parenteral’s Ltd. | Healthcare | 1.15% | ₹3.75 Cr | — | — | — |
| Astrazeneca Pharma India Ltd. | Healthcare | 1.14% | ₹3.71 Cr | — | — | — |
| Orchid Pharma Ltd. | Healthcare | 1.13% | ₹3.69 Cr | +1.66% | +0.42% | — |
| Dr. Lal Pathlabs Ltd. | Healthcare | 0.91% | ₹2.98 Cr | +2.96% | +2.79% | — |
| Medi Assist Healthcare Services Ltd. | Services | 0.83% | ₹2.72 Cr | +1.02% | +0.87% | — |
| Viyash Scientific Limited | Healthcare | 0.77% | ₹2.53 Cr | +0.36% | — | — |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 10.48% | 9.74% | -0.74% |
| Global Health Ltd. | 2.45% | 1.88% | -0.57% |
| Max Healthcare Institute Ltd. | 5.81% | 5.27% | -0.54% |
| Ajanta Pharma Ltd. | 1.74% | 1.22% | -0.52% |
| Shilpa Medicare Ltd. | 3.72% | 4.17% | +0.45% |
| Lupin Ltd. | 3.96% | 4.35% | +0.39% |
| Novartis India Ltd. | 1.50% | 1.88% | +0.38% |
| Healthcare Global Enterprises Ltd. | 1.66% | 1.33% | -0.33% |
| Pfizer Ltd. | 1.84% | 1.54% | -0.30% |
| Dr. Reddy's Laboratories Ltd. | 3.48% | 3.78% | +0.30% |
| Glaxosmithkline Pharmaceuticals Ltd. | 3.68% | 3.39% | -0.29% |
| Alivus Life Sciences Ltd | 1.36% | 1.15% | -0.21% |
| Cipla Ltd. | 6.38% | 6.18% | -0.20% |
| Jubilant Pharmova Ltd. | 1.46% | 1.26% | -0.20% |
| Sai Parenteral’s Ltd. | 0.95% | 1.15% | +0.20% |
| Eris Lifesciences Ltd. | 2.35% | 2.19% | -0.16% |
| Narayana Hrudayalaya Ltd. | 2.59% | 2.74% | +0.15% |
| Thyrocare Technologies Ltd. | 1.46% | 1.31% | -0.15% |
| Torrent Pharmaceuticals Ltd. | 3.36% | 3.23% | -0.13% |
| Astrazeneca Pharma India Ltd. | 1.26% | 1.14% | -0.12% |
| Apollo Hospitals Enterprise Ltd. | 5.64% | 5.75% | +0.11% |
| Glenmark Pharmaceuticals Ltd. | 2.24% | 2.14% | -0.10% |
| Rainbow Children's Medicare Ltd. | 2.13% | 2.21% | +0.08% |
| Viyash Scientific Limited | 0.85% | 0.77% | -0.08% |
| Sai Life Sciences Ltd. | 1.10% | 1.17% | +0.07% |
| Gland Pharma Ltd. | 3.05% | 3.11% | +0.06% |
| Medi Assist Healthcare Services Ltd. | 0.89% | 0.83% | -0.06% |
| Orchid Pharma Ltd. | 1.08% | 1.13% | +0.05% |
| Aurobindo Pharma Ltd. | 4.14% | 4.10% | -0.04% |
| Syngene International Ltd. | 2.42% | 2.46% | +0.04% |
| Zydus Lifesciences Ltd. | 2.78% | 2.82% | +0.04% |
| Dr. Lal Pathlabs Ltd. | 0.88% | 0.91% | +0.03% |
| Divi's Laboratories Ltd. | 4.28% | 4.27% | -0.01% |
| Ipca Laboratories Ltd. | 1.49% | 1.48% | -0.01% |
| Sanofi India Ltd. | 1.51% | 1.50% | -0.01% |
| Others | 0.03% | 0.04% | +0.01% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹2,934 Cr | 1.89% | 36.5% | 20.8% | 21.6% |
 SBI Healthcare Opportunities Fund | ₹6,067 Cr | 1.98% | 35.0% | 19.9% | 22.6% |
 HDFC Pharma And Healthcare Fund | ₹3,501 Cr | 2.11% | 39.6% | 25.8% | — |
 Mirae Asset Healthcare Fund | ₹3,494 Cr | 2.01% | 37.3% | 20.2% | 21.1% |
 UTI Healthcare Fund | ₹1,430 Cr | 2.21% | 30.6% | 18.4% | 21.1% |
 ICICI Prudential Nifty Pharma Index Fund | ₹177 Cr | 1.13% | 39.9% | 19.9% | — |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
Fund managers
- Brijesh ShahMr. Shah is a Post Graduate Diploma in Finance.Prior to joining Bandhan Mutual Fund (formerly IDFC Mutual Fund) he has worked with IDBI Mutual Fund, IndiaBulls Mutual Fund, Mata Securities & Twenty First Century.
- Gaurav SatraMr. Satra has done B.Com and CAPrior to joining Bandhan Mutual Fund, he has worked with various Consultancy Firms as a CA
- Viraj KulkarniMr. Kulkarni is a B.Tech. (Electronics), CFA and also holds a PGDM (Finance).Prior to joining Bandhan Mutual Fund (formerly IDFC Mutual Fund) he was associated with Franklin Templeton Asset Management (India) Pvt. Ltd. (May 2014-Sept. 2015) and Goldman Sachs Services India (June 2010-May 2012).
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months11.68% absolute | ₹60,000 | ₹67,008 | 11.68% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.